RESÚMENES ENERO 2010

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

5 - Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis

Jorge M. Tamayo, Carlos A. Zarate Jr., Eduard Vieta, Gustavo Vázquez and Mauricio Tohen

The International Journal of Neuropsychopharmacology. Published online 04 Feb 2010

 

5 - Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis

Konstantinos N Fountoulakis, Xenia Gonda, Eduard Vieta and Frank Schmidt

Annals of General Psychiatry 2009, 8:27

 

GRATIS 3 - 5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats

Stacey J. Sukoff Rizzo, Claudine Pulicicchio, Jessica E. Malberg, Terrance H. Andree, Gary P. Stack, Zoë A. Hughes, Lee E. Schechter and Sharon Rosenzweig-Lipson

The International Journal of Neuropsychopharmacology, Vol. 12, Issue 08, pp 1045-1053

 

3 - Increased right amygdala volume in lithium-treated patients with bipolar I disorder

J. Usher, P. Menzel, T. Schneider-Axmann, C. Kemmer, W. Reith, P. Falkai, O. Gruber, H. Scherk

Acta Psychiatrica Scandinavica. Volume 121 Issue 2, Pages 119 - 124

 

3 - The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Bipolar Depression

Arash Ansari, and David N. Osser

Harvard Review of Psychiatry. January-February 2010, Vol. 18, No. 1, Pages 36-55

 

5 - Antidepressant Drug Effects and Depression Severity. A Patient-Level Meta-analysis

Jay C. Fournier, Robert J. DeRubeis, Steven D. Hollon, Sona Dimidjian, Jay D. Amsterdam, Richard C. Shelton, Jan Fawcett

JAMA. 2010;303(1):47-53

 

3 - Noninvasive Brain Stimulation With High-Frequency and Low-Intensity Repetitive Transcranial Magnetic Stimulation Treatment for Posttraumatic Stress Disorder

Paulo Sergio Boggio, Martha Rocha, Maira Okada Oliveira, Shirley Fecteau, Roni B. Cohen, Camila Campanhã, Eduardo Ferreira-Santos, Alexandrina Meleiro, Felipe Corchs, Soroush Zaghi, Alvaro Pascual-Leone, and Felipe Fregni

J Clin Psychiatry. Online ahead of print: December 29, 2009.

 

3 - Melancholic symptoms as assessed by the Hamilton Depression Rating Scale and outcomes with and without electroconvulsive therapy on an in-patient mood disorders unit

Keith G. Rasmussen, Susanna R. Stevens, Simon Kung, Amit Mohan

Acta Neuropsychiatrica. Volume 22 Issue 1, Pages 21 - 25.

 

GRATIS 3! - Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants

Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, et al.

PLoS ONE 2010; 5(1): e8566.

 

3 - Effect of Depression Treatment on Chronic Pain Outcomes

Carrie Farmer Teh, Alan M. Zaslavsky, Charles F. Reynolds, III, and Paul D. Cleary

Psychosomatic Medicine 72:61-67 (2010).

3 - Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder

Maria Eugenia Hernandez, Daniel Martinez-Fong, Mayra Perez-Tapia, Iris Estrada-Garcia, Sergio Estrada-Parra and Lenin Pavón

European Neuropsychopharmacology. Volume 20, Issue 2, February 2010, Pages 88-95.

 

3 - Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: A flow cytometric analysis

Ayşe Devrim Başterzi, Kemal Yazici, Visal Buturak, Burak Çimen, Aylin Yazici, Gülçin Eskandari, Şenel Tot Acar and Bahar Taşdelen

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 34, Issue 1, 1 February 2010, Pages 70-75.

 

5< - Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder

Antonio E. Nardi, Fabiana L. Lopes, Alexandre M. Valença, Rafael C. Freire, Isabella Nascimento, Andre B. Veras, Marco A. Mezzasalma, Valfrido L. de-Melo-Neto, Gastão L. Soares-Filho, Anna Lucia King, Leila O. Grivet, Arabella Rassi and Marcio Versiani

Psychiatry Research. Volume 175, Issue 3, 28 February 2010, Pages 260-265.

 

3! - Antidepressant Pharmacotherapy in Adults with Type 2 Diabetes: Rates and Predictors of Initial Response

Ryan J. Anderson, Britt M. Gott, Gregory S. Sayuk, Kenneth E. Freedland, and Patrick J. Lustman

Diabetes Care. Published online December 23, 2009.

 

3! - Pregnancy with epilepsy: Obstetric and neonatal outcome of a controlled study

G. Mawer, M. Briggs, G.A. Baker, R. Bromley, H. Coyle, J. Eatock, L. Kerr, U. Kini, L. Kuzmyshcheva, S.B. Lucas, L. Wyatt, J. Clayton-Smith and Liverpool & Manchester Neurodevelopment Group

Seizure. Article in Press 2010.

 

5< - Report of Two Double-Blind Randomized Placebo-Controlled Pilot Studies of a Carbohydrate-Rich Nutrient Mixture for Treatment of Seasonal Affective Disorder (SAD)

David Mischoulon, Paola Pedrelli, Judith Wurtman, Mark Vangel & Richard Wurtman

CNS Neuroscience & Therapeutics. Volume 16 Issue 1, Pages 13 - 24.

 

3! - Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder

Troy Lisa Holbrook, Michael R. Galarneau, Judy L. Dye, Kimberly Quinn, and Amber L. Dougherty

NEJM. Volume 362:110-117; January 14, 2010.

 

GRATIS 3! - Role of the Amygdala in Antidepressant Effects on Hippocampal Cell Proliferation and Survival and on Depression-like Behavior in the Rat

Castro JE, Varea E, Márquez C, Cordero MI, Poirier G, et al.

PLoS ONE 2010; 5(1): e8618.

 

GRATIS 3 - Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'

Konstantinos N Fountoulakis

Annals of General Psychiatry 2010, 9:3.

 

1!! - Is the antidepressive effect of second-generation antidepressants a myth?

P. Bech

Psychological Medicine (2010), 40:181-186 (2009), 40:181-186.

 

3! - Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R)

R. C. Kessler, H. Birnbaum, E. Bromet, I. Hwang, N. Sampson and V. Shahly

Psychological Medicine (2010), 40:225-237.

 

3! - Risk Factors for Non-Response in Inpatient Depression Treatment. Analysis of Routinely Collected Data in 511 Patients

Lars  Hölzel, Alessa von  Wolff, Levente  Kriston, Martin  Härter

Psychiat Prax 2010; 37(1): 27-33.

3! - Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report

A. F. Leuchter, M. M. Husain, I. A. Cook, M. H. Trivedi, S. R. Wisniewski, W. S. Gilmer, J. F. Luther, M. Fava and A. J. Rush

Psychological Medicine (2010), 40:239-251.

 

3 - 5-HT1A Autoreceptor Levels Determine Vulnerability to Stress and Response to Antidepressants

Jesse W. Richardson-Jones, Caryne P. Craige, Bruno P. Guiard, Alisson Stephen, Kayla L. Metzger, Hank F. Kung, Alain M. Gardier, Alex Dranovsky, Denis J. David, Sheryl G. Beck, René Hen and E. David Leonardo

Neuron. Volume 65, Issue 1, 14 January 2010, Pages 40-52.

 

3! - Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study




References and further reading may be available for this article. To view references and further reading you must
purchase this article.

I. Romera, V. Perez, J.M. Menchón, H. Delgado-Cohen, P. Polavieja and I. Gilaberte

European Psychiatry. Volume 25, Issue 1, January 2010, Pages 58-65.

 

3 - Perinatal use of anticonvulsants: differences in attitudes and recommendations among neurologists and psychiatrists

Adele C. Viguera, Lee S. Cohen, Theodore Whitfield, Alison M. Reminick, Edward Bromfield and Ross J. Baldessarini

Archives of Women's Mental Health. Online First, January 2010.

 

3< - Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy

Nikos Triantafyllou, Irini Lambrinoudaki, Elena Armeni, Eleftheria-Maria Evangelopoulos, Fotini Boufidou, Aris Antoniou and Georgios Tsivgoulis

Journal of the Neurological Sciences. Volume 290, Issues 1-2, 15 March 2010, Pages 131-134.

 

3 - Effects of the Serotonin 1A, 2A, 2C, 3A, and 3B and Serotonin Transporter Gene Polymorphisms on the Occurrence of Paroxetine Discontinuation Syndrome

Murata, Yusuke; Kobayashi, Daisuke; Imuta, Nanae; Haraguchi, Koichi; Ieiri, Ichiro; Nishimura, Ryoji; Koyama, Susumu; Mine, Kazunori

Journal of Clinical Psychopharmacology: February 2010 - Volume 30 - Issue 1 - pp 11-17.

 

5 - Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder: Results of a Randomized Trial

Rickels, Karl; Montgomery, Stuart A; Tourian, Karen A; Guelfi, Julien D; Pitrosky, Bruno; Padmanabhan, Sudharshan Krishna; Germain, Jean-Michael; Leurent, Claire; Brisard, Claudine

Journal of Clinical Psychopharmacology: February 2010 - Volume 30 - Issue 1 - pp 18-24.

 

4 - A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder

Stewart, S. Evelyn; Jenike, Eric A; Hezel, Dianne M; Stack, Denise Egan; Dodman, Nicholas H; Shuster, Louis; Jenike, Michael A

Journal of Clinical Psychopharmacology: February 2010 - Volume 30 - Issue 1 - pp 34-39.

 

3 - Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157

Joanna S Fowler, Jean Logan, Albert J Azzaro, Robert M Fielding, Wei Zhu, Amy K Poshusta, Daniel Burch, Barry Brand, James Free, Mahnaz Asgharnejad, Gene-Jack Wang, Frank Telang, Barbara Hubbard, Millard Jayne, Payton King, Pauline Carter, Scott Carter, Youwen Xu, Colleen Shea, Lisa Muench, David Alexoff, Elena Shumay, Michael Schueller, Donald Warner and Karen Apelskog-Torres

Neuropsychopharmacology (2010) 35, 623–631.

 

3 - Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

Sonja Horstmann, Susanne Lucae, Andreas Menke, Johannes M Hennings, Marcus Ising, Darina Roeske, Bertram Müller-Myhsok, Florian Holsboer and Elisabeth B Binder

Neuropsychopharmacology (2010) 35, 727–740.

 

3 - Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole

Brian P Brennan, James I Hudson, J Eric Jensen, Julie McCarthy, Jacqueline L Roberts, Andrew P Prescot, Bruce M Cohen, Harrison G Pope Jr, Perry F Renshaw and Dost Öngür

Neuropsychopharmacology (2010) 35, 834–846.

 

5 - Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study

Mohammad Reza Safarinejad

Journal of Psychopharmacology First published on January 15, 2010.

5 - The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study

Mohammad Reza Safarinejad

BJU International. Early View. Published Online: 8 Jan 2010.

 

3 - Antidepressant Medication and Executive Dysfunction: A Deleterious Interaction in Late-Life Depression

Sneed, Joel R; Culang, Michelle E; Keilp, John G; Rutherford, Bret R; Devanand, Davangere P; Roose, Steven P

American Journal of Geriatric Psychiatry: February 2010 - Volume 18 - Issue 2 - pp 128-135.

 

5< - Improving Depression and Enhancing Resilience in Family Dementia Caregivers: A Pilot Randomized Placebo-Controlled Trial of Escitalopram

Lavretsky, Helen; Siddarth, Prabha; Irwin, Michael R

American Journal of Geriatric Psychiatry: February 2010 - Volume 18 - Issue 2 - pp 154-162.

 

3 - Psychiatric Disorders and Cognitive Dysfunction Among Older, Postmenopausal Women: Results From the Women's Health Initiative Memory Study

Colenda, Christopher C; Legault, Claudine; Rapp, Stephen R; DeBon, Margaret W; Hogan, Patricia; Wallace, Robert; Hershey, Linda; Ockene, Judith; Whitmer, Rachael; Phillips, Lawrence S; Sarto, Gloria E

American Journal of Geriatric Psychiatry: February 2010 - Volume 18 - Issue 2 - pp 177-186.

 

3! - α2-Adrenoceptor Blockade Accelerates the Neurogenic, Neurotrophic, and Behavioral Effects of Chronic Antidepressant Treatment

Sudhirkumar U. Yanpallewar, Kimberly Fernandes, Swananda V. Marathe, Krishna C. Vadodaria, Dhanisha Jhaveri, Karen Rommelfanger, Uma Ladiwala, Shanker Jha, Verena Muthig, Lutz Hein, Perry Bartlett, David Weinshenker, and Vidita A. Vaidya

The Journal of Neuroscience, January 20, 2010, 30(3):1096-1109.

 

5< - Efficacy of Sodium Valproate and Haloperidol in the Management of Acute Mania: A Randomized Open-Label Comparative Study

Susmit Sekhar, Bhupinder Kalra, D. N. Mendhekar, and Uma Tekur

The Journal of Clinical Pharmacology First published on January 14, 2010.

GRATIS 3 - Advantages of Using Estimated Depression-Free Days for Evaluating Treatment Efficacy

Steven D. Vannoy, Patricia Arean, and Jürgen Unützer

Psychiatr Serv 61:160-163, February 2010.

GRATIS 3! - One-Year Treatment Outcomes of African-American and Hispanic Patients With Bipolar I or II Disorder in STEP-BD

Jodi M. Gonzalez, Charles L. Bowden, Nancy Berman, Ellen Frank, Mark S. Bauer, Jane N. Kogan, Margarita Alegría, and David J. Miklowitz

Psychiatr Serv 61:164-172, February 2010.

3 - Risperidone in the treatment of mixed state bipolar patients: Results from a 24-week, multicenter, open-label study in Korea

Young Sup Woo, Won-Myong Bahk, Duk-In Jon, Sang-Keun Chung, Sang-Yeol Lee, Yong Min Ahn, Chi-Un Pae, Hyun-Sang Cho, Jeong-Gee Kim, Tae-Yeon Hwang, Hong-Seok Lee, Kyung Joon Min, Kyung-Uk Lee, and Bo-Hyun Yoon

Psychiatry and Clinical Neurosciences. Volume 64 Issue 1, Pages 28 - 37.

 

3 - Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge

Sean D Hood, Jan K Melichar, Lindsay G Taylor, Nicola Kalk, Tom R Edwards, Dana A Hince, Alan Lenox-Smith, Anne R Lingford-Hughes, and David J Nutt

Journal of Psychopharmacology First published on January 21, 2010.

5 - Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis

Nuria Cruz, Jose Sanchez-Moreno, Ferran Torres, Jose Manuel Goikolea, Marc Valentí and Eduard Vieta

The International Journal of Neuropsychopharmacology (2010), 13:5-14.

 

3! - Do atypical features affect outcome in depressed outpatients treated with citalopram?

Jonathan W. Stewart, Patrick J. McGrath, Maurizio Fava, Stephen R. Wisniewski, Sidney Zisook, Ian Cook, Andrew A. Nierenberg, Madhukar H. Trivedi, G. K. Balasubramani, Diane Warden, Ira Lesser and A. John Rush

The International Journal of Neuropsychopharmacology (2010), 13:15-30.

 

5 - Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm

Ulrich Hegerl, Martin Hautzinger, Roland Mergl, Ralf Kohnen, Michael Schütze, Winfried Scheunemann, Antje-Kathrin Allgaier, James Coyne and Verena Henkel

The International Journal of Neuropsychopharmacology (2010), 13:31-44.

 

5< - Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [18F]-fluorodeoxyglucose PET and MRI study

Marie-Laure Paillère Martinot, André Galinowski, Damien Ringuenet, Thierry Gallarda, Jean-Pascal Lefaucheur, Frank Bellivier, Christine Picq, Pascale Bruguière, Jean-François Mangin, Denis Rivière, Jean-Claude Willer, Bruno Falissard, Marion Leboyer, Jean-Pierre Olié, Eric Artiges and Jean-Luc Martinot

The International Journal of Neuropsychopharmacology (2010), 13:45-59.

 

5< - A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression

Colleen K. Loo, Perminder Sachdev, Donel Martin, Melissa Pigot, Angelo Alonzo, Gin S. Malhi, Jim Lagopoulos and Philip Mitchell

The International Journal of Neuropsychopharmacology (2010), 13:61-69.

 

5< - Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

Sanjay J. Mathew, James W. Murrough, Marije aan het Rot, Katherine A. Collins, David L. Reich and Dennis S. Charney

The International Journal of Neuropsychopharmacology (2010), 13:71-82.

 

3! - Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants

Angela Matuzany-Ruban, Moran Golan, Nataly Miroshnik, Gabriel Schreiber and Sofia Avissar

The International Journal of Neuropsychopharmacology (2010), 13:83-91.

 

3 - Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response

Katharina Domschke, Bruce Lawford, Gonzalo Laje, Klaus Berger, Ross Young, Phillip Morris, Jürgen Deckert, Volker Arolt, Francis J. McMahon and Bernhard T. Baune

The International Journal of Neuropsychopharmacology (2010), 13:93-101.

 

3 - Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment

Annamaria Cattaneo, Luisella Bocchio-Chiavetto, Roberta Zanardini, Elena Milanesi, Anna Placentino and Massimo Gennarelli

The International Journal of Neuropsychopharmacology (2010), 13:103-108.

 

3 - Therapeutic Options for Treatment-Resistant Depression

Shelton, Richard C; Osuntokun, Olawale; Heinloth, Alexandra N; Corya, Sara A

CNS Drugs: 1 February 2010 - Volume 24 - Issue 2 - pp 131-161.

 

3 - Clinical Outcomes and Low-Dose Levocarnitine Supplementation in Psychiatric Inpatients With Documented Hypocarnitinemia: A Retrospective Chart Review

Cuturic, Miroslav; Abramson, Ruth K; Moran, Robert R; Hardin, James W

Journal of Psychiatric Practice: January 2010 - Volume 16 - Issue 1 - pp 5-14.

 

3 - Cyclothymic temperament and major depressive disorder: A study on Italian patients

Giuseppe Maina, Virginio Salvi, Gianluca Rosso and Filippo Bogetto

Journal of Affective Disorders. Volume 121, Issue 3, March 2010, Pages 199-203.

 

3 - Antidepressants, social adversity and outcome of depression in general practice

George W. Brown, Tirril O. Harris, Tony Kendrick, Judy Chatwin, Tom K.J. Craig, Vikki Kelly, Helen Mander, Adele Ring, Vuokko Wallace, Rudolf Uher and Thread Study Group

Journal of Affective Disorders. Volume 121, Issue 3, March 2010, Pages 239-246.

 

3! - Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence

Danielle M Novick, Holly A Swartz and Ellen Frank

Bipolar Disorders. Volume 12 Issue 1, Pages 1 - 9.

 

3! - Does lithium protect against dementia?

Lars Vedel Kessing, Julie Lyng Forman and Per Kragh Andersen

Bipolar Disorders. Volume 12 Issue 1, Pages 87 - 94.

 

3 - Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions

Carol A. Pamer, Tarek A. Hammad, Yu-te Wu, Sigal Kaplan, George Rochester, Laura Governale, Andrew D. Mosholder

Pharmacoepidemiology and Drug Safety. Volume 19 Issue 2, Pages 158 - 174.

 

3 - The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): A feature of its antidepressant activity?

Francesco Crespi

Neuroscience Letters. Volume 470, Issue 2, 12 February 2010, Pages 95-99.

 

3 - Prescribing a Sedative Antidepressant for Patients at Work or on Sick Leave under Conditions of Routine Care

M. Linden, A. Westram

Pharmacopsychiatry 2010; 43(1): 1-6.

3 - Cardiac Effects of Vagus Nerve Stimulation in Patients with Major Depression

W. Sperling, U. Reulbach, S. Bleich, F. Padberg, J. Kornhuber, M. Mueck-Weymann

Pharmacopsychiatry 2010; 43(1): 7-11.

3 - Antipsychotic use Patterns in Persons Initially Treated with Mood Stabilizers: A Naturalistic Study

H. Verdoux, A. Cougnard, G.-R. Auleley, J. Deligne, C. Blum-Boisgard, B. Bégaud, M. Tournier

Pharmacopsychiatry 2010; 43(1): 17-23.

3 - Effect of mood stabilizers on gene expression in lymphoblastoid cells

Hiroko Sugawara, Kazuya Iwamoto, Miki Bundo, Mizuho Ishiwata, Junko Ueda, Chihiro Kakiuchi, Jun Ishigooka and Tadafumi Kato

Journal of Neural Transmission. Volume 117, Number 2 / February, 2010: 155-164.

 

3 - Does Valproic Acid Warrant Therapeutic Drug Monitoring in Bipolar Affective Disorder?

Haymond, Jennifer; Ensom, Mary H H

Therapeutic Drug Monitoring: February 2010 - Volume 32 - Issue 1 - pp 19-29.

 

5 - Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials? Results From Pooled and Meta-Analyses

Mark Sinyor, Anthony J. Levitt, Amy H. Cheung, Ayal Schaffer, Alex Kiss, Yekta Dowlati, and Krista L. Lanctôt

J Clin Psychiatry. Online First, January 2010.

 

5 - A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I)

Allan H. Young, Susan L. McElroy, Michael Bauer, Nabil Philips, William Chang, Bengt Olausson, Björn Paulsson, and Martin Brecher, for the EMBOLDEN I (Trial 001) Investigators

J Clin Psychiatry. Online First, January 2010.

 

5 - A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Susan L. McElroy, Richard H. Weisler, William Chang, Bengt Olausson, Björn Paulsson, Martin Brecher, Vasavan Agambaram, Charles Merideth, Arvid Nordenhem, and Allan H. Young, for the EMBOLDEN II (Trial D1447C00134) Investigators

J Clin Psychiatry. Online First, January 2010.

 

3! - Psychiatric Diagnoses in Patients Previously Overdiagnosed With Bipolar Disorder

Mark Zimmerman, Camilo J. Ruggero, Iwona Chelminski, and Diane Young

J Clin Psychiatry 2010;71(1):26-31.

 

3 - A simpler definition of major depressive disorder

M. Zimmerman, J. N. Galione, I. Chelminski, J. B. McGlinchey, D. Young, K. Dalrymple, C. J. Ruggero and C. Francione Witt

Psychological Medicine (2010), 40:451-457.

 

3! - Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

The BALANCE investigators and collaborators

The Lancet. Volume 375, Issue 9712, 30 January 2010-5 February 2010, Pages 385-395.

 

3! - Dysthymia Before Myocardial Infarction as a Cardiac Risk Factor at 2.5-Year Follow-Up

Chiara Rafanelli, Yuri Milaneschi, Renzo Roncuzzi, and Leonardo G. Pancaldi

Psychosomatics 51:8-13, January-February 2010.

GRATIS 3! - An Increased Risk of Stroke Among Panic Disorder Patients: A 3-Year Follow-up Study

Yi-Hua Chen, Chaur-Jong Hu, Hsin-Chien Lee, Herng-Ching Lin

Can J Psychiatry. 2010;55(1):43–49

 

GRATIS 2 - Low-dose Transdermal Testosterone Augmentation Therapy Improves Depression Severity in Women

Karen K. Miller, Roy H. Perlis, George I. Papakostas, David Mischoulon, Dan V. Iosifescu, Danielle J. Brick, and Maurizio Fava

CNS Spectr. 2009;14(12):688-694

 

GRATIS 3 - An Evaluation of the Efficacy, Safety, and Tolerability of Desvenlafaxine in the Long-term Treatment of Elderly Outpatients With Major Depressive Disorder

James Ferguson, Karen A. Tourian, Amy L. Manley, S. Krishna Padmanabhan, and Alice Nichols

Primary Psychiatry. 2010;17(1):66-73

  

 



Regresar a RESÚMENES ENERO 2010


© 1999-2010 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

 

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA